Dublin, May 20, 2024 (GLOBE NEWSWIRE) -- The "United States Platelet Rich Plasma Market Report by Product Type, Origin, Application, End User, and Region 2024-2032" report has been added to ResearchAndMarkets.com's offering.

The United States platelet rich plasma market size reached US$ 249.6 Million in 2023. Looking forward, the market is projected to reach US$ 546.2 Million by 2032, exhibiting a growth rate (CAGR) of 9.09% during 2023-2032.

The rising prevalence of chronic tendon injuries in vital organs is currently bolstering the demand for PRP-based therapies in the US. Furthermore, increasing adoption of effective therapies for treating muscle and acute ligament tearing, arthritis, fractures, orthopedic impairments, etc., is also propelling the market growth.

In line with this, the growing awareness towards numerous benefits of PRP treatment in preventing inflammation, encouraging new cartilage formulation, and inducing natural lubrication fluid production, is further augmenting the product demand in the country.

Moreover, the rising deployment of advanced healthcare facilities for sports clubs and teams is also catalyzing the adoption of PRP-based therapies for treating common injuries in athletes, such as lumbar spine disc pain, rotator cuff injuries, shoulder pain and instability, tennis/golfer's elbow, etc. Apart from this, the expanding cosmetic surgery sector in the United States is further driving the utilization of PRP-based procedures for improving facial shape and volume.

In the coming years, the increasing healthcare expenditures along with the rising demand for non-invasive medical procedures will continue to spur the demand for PRP-based therapies in the United States.

Key Questions Answered in This Report

• What was the size of the United States platelet rich plasma market in 2023?
• What is the expected growth rate of the United States platelet rich plasma market during 2024-2032?
• What are the key factors driving the United States platelet rich plasma market?
• What has been the impact of COVID-19 on the United States platelet rich plasma market?
• What is the breakup of the United States platelet rich plasma market based on the product type?
• What is the breakup of the United States platelet rich plasma market based on the origin?
• What is the breakup of the United States platelet rich plasma market based on the application?
• What is the breakup of the United States platelet rich plasma market based on the end user?
• What are the key regions in the United States platelet rich plasma market?
• Who are the key players/companies in the United States platelet rich plasma market?

Key Attributes:

Companies Featured

• Arteriocyte Medical Systems Inc. (Isto Technologies II LLC)
• Arthrex Inc.
• Depuy Synthes Inc. (Johnson & Johnson)
• Dr Prp USA LLC
• EmCyte Corporation
• Exactech Inc.
• Glofinn America LLC (Glofinn Co. Ltd.)
• Regen Lab USA LLC
• Stryker Corporation
• Terumo BCT Inc. (Terumo Corporation)
• ThermoGenesis Holdings Inc.
• Zimmer Biomet Holdings Inc.

Key Market Segmentation

Breakup by Product Type:

• Pure Platelet-Rich Plasma (P-PRP)
• Leukocyte- and Platelet-Rich Plasma (LPRP)
• Leukocyte- and Platelet-Rich Fibrin (L-PRF)
• Pure Platelet-Rich Fibrin (P-PRF)

Breakup by Origin:

• Autologous PRP
• Homologous PRP
• Allogeneic PRP

Breakup by Application:

• Orthopedics
• Cosmetic Surgery and Dermatology
• Neurosurgery
• General Surgery
• Cardiothoracic Surgery
• Urology
• Ophthalmology
• Others

Breakup by End User:

• Hospitals and Clinics
• Research Institutes
• Others

Breakup by Region:

• Northeast
• Midwest
• South
• West

For more information about this report visit https://www.researchandmarkets.com/r/sjsuy4

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Attachment

• U.S. Platelet Rich Plasma Market